Cosmetics regulation

MoCRA Fragrance Allergen Labeling: Has FDA Published the List?

Where the US fragrance allergen labeling rule stands under MoCRA, what the law tells FDA to weigh, and what a brand can check in its fragrance suppliers’ statements before the list exists.

6 min read

Not yet. As of November 8, 2026, FDA has not published a list of the fragrance allergens a US cosmetic label must name, and it has not published the proposed rule that would create one. The Modernization of Cosmetics Regulation Act of 2022, known as MoCRA, requires that list and gave FDA until June 2024 to propose it. FDA’s regulatory agenda now says November 2026, the fourth date it has given.

When the list arrives, a brand will apply it from a document it does not write: the allergen statement from its fragrance supplier. This article sets out what the law requires, where FDA’s proposal stands, what the law tells FDA to weigh, and what a brand can check in its files now.

What MoCRA requires on fragrance allergens

MoCRA added section 609 to the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. 364e. Subsection (b) says the responsible person, meaning the manufacturer, packer or distributor whose name appears on the label, “shall identify on the label of a cosmetic product each fragrance allergen included in such cosmetic product.”

The same subsection leaves the content to FDA: “Substances that are fragrance allergens for purposes of this subsection shall be determined by the Secretary by regulation.” The Secretary is the Secretary of Health and Human Services, and FDA is writing the rule. Until that regulation exists, no substance carries that status under the statute.

Under 21 U.S.C. 362(b), a cosmetic in package form is misbranded, the Act’s term for a product whose labeling breaks its rules, unless its label carries “the information required under section 364e of this title.” The statute’s small-business exemption, 21 U.S.C. 364h, refers to the sections on good manufacturing practice and on registration and product listing. It does not mention the labeling section.

Today a US ingredient list can simply say “fragrance.” FDA’s labeling regulation, 21 CFR 701.3(a), requires a declaration of each ingredient “except that fragrance or flavor may be listed as fragrance or flavor.” FDA’s web page on allergens in cosmetics does list fragrance allergens, but it attributes that list to Annex III of the EU’s cosmetics rules and does not say US labels have to name them.

Where FDA’s proposal stands

FDA’s planned rules appear in the Unified Agenda, the federal government’s twice-yearly report of regulatory activity under development. This one is listed under regulation identifier number (RIN) 0910-AI90 as “Disclosure of Fragrance Allergens in Cosmetic Labeling.” Its abstract reads: “FDA is proposing to identify certain substances as fragrance allergens and to require the disclosure of fragrance allergens on the labels of cosmetic products.”

The statute set the deadline for the proposal at “not later than 18 months after December 29, 2022,” which the agenda records as June 29, 2024. That deadline has passed, and the agenda’s own date has moved with each edition:

When FDA’s agenda listed the proposed rule, RIN 0910-AI90
Agenda edition Proposed rule listed for
Spring 2024 October 2024
Fall 2024 January 2025
Spring 2025 May 2026
2026 Regulatory Plan and Unified Agenda November 2026

An agenda date is a plan, and each of the first three has passed without a proposal. A search of the Federal Register on November 8, 2026 found nothing under that RIN, and nothing from FDA on “fragrance allergens” in 2026. The public inspection list, which shows documents filed for upcoming publication, held no FDA document through the filings of November 6.

When the proposal does appear, the statute starts a second clock. A final rule is due “not later than 180 days after the date on which the public comment period on the proposed rulemaking closes.” The statute gives no date by which labels must change.

What the law tells FDA to weigh

The statute does not say what the list will contain. It says what FDA has to look at and what FDA is allowed to do: “the Secretary shall consider international, State, and local requirements for allergen disclosure, including the substance and format of requirements in the European Union, and may establish threshold levels of amounts of substances subject to disclosure pursuant to such regulations.”

Two words carry that sentence. Consider requires FDA to look at the EU’s rules, not to adopt them. May allows thresholds without requiring them.

The EU’s rule is the reference the statute names. Under Article 19(1)(g) of Regulation (EC) No 1223/2009, a fragrance appears in the ingredient list as “parfum” or “aroma,” and the substances Annex III requires to be mentioned are named in addition. Regulation (EU) 2023/1545 counts 24 fragrance allergens already labeled individually and adds 56 more, to be named when they exceed 0.001% of a leave-on product, which stays on the skin or hair, or 0.01% of a rinse-off product, which is washed off. The article on EU fragrance allergen labeling sets out what changed and by when.

None of that settles what FDA will propose. It does show what kind of information a list with thresholds asks for.

Why the answer runs through the fragrance supplier

Take one fragrance in one body lotion. An allergen’s level in the lotion is its level in the fragrance multiplied by the fragrance’s level in the lotion. Say the fragrance contains 0.5% linalyl acetate, one of the allergens the EU added, and makes up 1% of the lotion. The lotion then contains 0.005% linalyl acetate. In the EU that is above the leave-on threshold, so the name goes on the label. No US threshold exists to read that figure against, but a threshold set on the finished product would be read the same way.

The two numbers come from different places. The fragrance’s level in the lotion is the brand’s own, in its formula. The allergen’s level in the fragrance normally sits with the fragrance supplier, and it reaches the brand in an allergen statement. What that statement contains decides what the brand can answer:

  • Names only. A statement that says which allergens a fragrance contains, with no levels, can answer a question about presence. It cannot answer a question about a threshold.
  • Names with levels in the fragrance. The brand can multiply by its own dose and reach the level in the finished product.
  • A statement written against a shorter list. A statement that covers only some allergens is silent about the rest, and silence does not mean the fragrance is free of them.

What a brand can check now

The regulation is FDA’s to write. Knowing which statements carry levels is work a brand can do today, whatever the list turns out to name.

  • For each scented product sold in the US, record the fragrance, its supplier, its dose in the product, and whether the product is leave-on or rinse-off.
  • For each fragrance, find the current allergen statement and record its issue date and the allergens it covers.
  • Mark whether it gives levels or only names, and whether any level is stated for the fragrance or for the finished product.
  • Where a statement gives names only, ask the supplier whether levels can be provided.
  • Treat a changed fragrance, supplier or dose as a reason to recheck the products that depend on it.
  • Watch the Federal Register for RIN 0910-AI90. The statute provides for a public comment period on the proposal, and that period is the time to read it against these files.

Whether the check runs in a spreadsheet or in software, the job is the same: read what the supplier sent, compare it with the brand’s own formula, and keep the source of every value. It is the kind of reconciliation Smart-Suited Tech’s document agent, Elara, performs on other supplier paperwork.

The list is FDA’s to publish, on a date that has moved three times. Which of a brand’s fragrance statements carry levels can be known now.

Sources

  1. 01 21 U.S.C. 364e: Labeling (section 609 of the Federal Food, Drug, and Cosmetic Act), subsection (b) — United States Code, added by Pub. L. 117-328, December 29, 2022
  2. 02 21 U.S.C. 364: Definitions, paragraph (4), “responsible person” — United States Code
  3. 03 21 U.S.C. 362: Misbranded cosmetics, subsection (b) — United States Code
  4. 04 21 U.S.C. 364h: Small businesses (section 612 of the Federal Food, Drug, and Cosmetic Act) — United States Code
  5. 05 21 CFR 701.3: Designation of ingredients — U.S. Food and Drug Administration, Code of Federal Regulations
  6. 06 Allergens in Cosmetics — U.S. Food and Drug Administration, content current as of October 9, 2026
  7. 07 Disclosure of Fragrance Allergens in Cosmetic Labeling, RIN 0910-AI90 — Unified Agenda, 2026 Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions; earlier editions at the same address
  8. 08 About the Unified Agenda — Office of Information and Regulatory Affairs, reginfo.gov
  9. 09 Federal Register search, “fragrance allergens” — Office of the Federal Register, read November 8, 2026
  10. 10 Federal Register public inspection, current list — Office of the Federal Register, read November 8, 2026
  11. 11 Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products — Official Journal of the European Union, L 342, December 22, 2009
  12. 12 Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in cosmetic products — Official Journal of the European Union, L 188, July 27, 2023

{{ kicker }}

{{ title }}

{{ summary }}

{{ readingLabel }}

This article's copy (content.js beside this page) could not be loaded.

{{ b.nodes }}

{{ b.text }}

{{ b.text }}
{{ b.cite }}
  • {{ li.nodes }}
{{ b.caption }}
{{ col.text }}
{{ cell.text }}

Sources

  1. {{ s.num }} {{ s.text }} {{ s.text }} — {{ s.meta }}

All lessons